Kidney Transplant Market Revenue to Attain USD 17.09 Bn by 2033

28 Jul 2025

Share :

Table of Content

1. Kidney Transplant Market Revenue and Trends 2025 to 2033 2. What are the Key Factors Driving the Growth of the Kidney Transplant Market? 3. Segment Outlook 4. Regional Insights 5. Kidney Transplant Market Coverage 6. Kidney Transplant Market Key Players

Kidney Transplant Market Revenue and Trends 2025 to 2033

The global kidney transplant market revenue reached USD 9.92 billion in 2025 and is predicted to attain around USD 17.09 billion by 2033 with a CAGR of 7.03%. The market growth is driven by the increasing prevalence of end-stage renal disease (ESRD) and advancements in transplant technologies and immunosuppressive therapies.

What are the Key Factors Driving the Growth of the Kidney Transplant Market?

The market for kidney transplant is experiencing significant growth, driven by the rapid increase in the global rates of chronic kidney disease (CKD) and end-stage renal disease (ESRD), especially within the aging population. Technological advancements in surgical procedures, organ preservation techniques, and immunosuppressive medications are increasing the success rates of transplant procedures. Moreover, growing awareness of organ donation, government initiatives supporting organ donation programs, and increased healthcare expenditures in developing countries open up new growth avenues. There is a strong emphasis on minimally invasive procedures, which further supports market growth.

Segment Outlook

• By donor type, the deceased donor segment maintained dominance in the market for kidney transplant by capturing the largest share in 2024. This is mainly due to the widespread availability of diseased organs and a well-established supply chain of diseased organ donors. Improved awareness of organ donation, organ retrieval methods, and supportive legislation further bolstered the segmental growth.
• By type of transplant, the non-preemptive kidney transplant segment held the largest share of the market in 2024 due to its proven effectiveness and safety. This is the case where patients are increasingly being diagnosed later in their illnesses, and there are people who want alternatives to dialysis.
• By end-user, the hospitals segment dominated the market in 2024. Due to the availability of sophisticated infrastructure, including cutting-edge preservation techniques and advanced surgical equipment, there has been a significant increase in the patient pool. These settings are considered the primary point of contact due to the availability of specialized services and complete post-transplant follow-up.
• By immunosuppressive drug, the maintenance therapy segment contributed the largest market share in 2024. This is mainly due to its essential role in ensuring long-term graft viability.
• By organ preservation solution, the University of Wisconsin (UW) solution segment led the market in 2024 due to its demonstrated effectiveness and continued utilization. It also improves graft preservation.
• By equipment/service type, the cross-matching and HLA typing services segment dominated the market, holding the largest share in 2024, due to their essential role in ensuring donor-recipient compatibility and minimizing the risk of graft rejection.

Regional Insights

North America registered dominance in the kidney transplant market in 2024 because of its sophisticated healthcare systems, increased awareness of organ donation, and government-led programs for organ donation and transplant processes. On the other hand, Asia Pacific is expected to grow at the fastest rate in the upcoming period due to the rising prevalence of chronic kidney disease, expanding access to quality healthcare, and increasing investments in transplant facilities.

Kidney Transplant Market Coverage

Recent Development

• On February 26, 2025, Paragonix Technologies announced the completion of the world’s first donor kidney transported utilizing commercial air travel while being continuously perfused in its FDA-cleared KidneyVault Portable Renal Perfusion System. (Source: https://www.paragonixtechnologies.com)

Kidney Transplant Market Key Players

• Novartis AG
• Astellas Pharma Inc.
• Sanofi S.A.
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd
• Veloxis Pharmaceuticals, Inc.
• Bristol-Myers Squibb Company
• Thermo Fisher Scientific Inc.
• BioLife Solutions, Inc.
• OrganOx Limited
• TransMedics, Inc.
• Dr. Franz Köhler Chemie GmbH
• XVIVO Perfusion AB
• BioTime, Inc. (Lineage Cell Therapeutics)
• Teva Pharmaceutical Industries Ltd.
• AbbVie Inc.
• Medtronic plc
• Zimmer Biomet
• Bio-Rad Laboratories, Inc.
• Immucor, Inc.

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6464

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.co |+1 804 441 9344